CRP and chronic kidney disease: After performing a sensitivity analysis on the entire cohort including patients without hsTnI measurement, age of at least 65 years old (OR 4.99, 95% CI 2.69–9.25), active cancer (OR 2.52, 95% CI 1.22–5.22), chronic kidney disease (OR 3.26, 95% CI 1.85–5.76), CRP elevation of at least 100 mg/L (OR 2.34, 95% CI 1.28–4.28), D-dimer elevation over 3000 μg/L (OR 1.95, 95% CI 1.04–3.52), and hsTnI elevation (OR 3.84, 95% CI 1.78–8.28) were significantly associated with death (Supplementary Table S1).